The trifecta of accelerating sales momentum, new product launches, and robust financial performance has paid off handsomely for Globus Medical Inc. (GMED), a musculoskeletal implant manufacturer. The stock hit an all-time high of $84.87 yesterday.
Last year, the company joined forces with spine specialist NUVASIVE (NUVA), in an all-stock deal valued at $3.1 billion, to create a combined company with highly complementary capabilities, geographic footprints, customer bases, and a compelling financial profile.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com